Hyperleptinemia results in systemic inflammation and the exacerbation of ischemia-reperfusion myocardial injury
Open Access
- 26 November 2021
- Vol. 7 (11) , e08491
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education and Science of the Russian Federation (075-15-2020-800)
This publication has 51 references indexed in Scilit:
- Identification of Fat Mass and Obesity Associated (FTO) Protein Expression in Cardiomyocytes: Regulation by Leptin and Its Contribution to Leptin-Induced HypertrophyPLOS ONE, 2013
- Hyperleptinemia is associated with parameters of low-grade systemic inflammation and metabolic dysfunction in obese human beingsFrontiers in Integrative Neuroscience, 2013
- Resource list for cognitive motor and sensory supports in persons with autismFrontiers in Integrative Neuroscience, 2013
- Elevated serum leptin levels in patients with acute myocardial infarction; correlation with coronary angiographic and echocardiographic findingsBMC Research Notes, 2012
- Inhibition of cardiac leptin expression after infarction reduces subsequent dysfunctionJournal of Cellular and Molecular Medicine, 2011
- Cardiac-specific leptin receptor deletion exacerbates ischaemic heart failure in miceCardiovascular Research, 2010
- Leptin attenuates cardiac apoptosis after chronic ischaemic injuryCardiovascular Research, 2009
- Leptin, the obesity‐associated hormone, exhibits direct cardioprotective effectsBritish Journal of Pharmacology, 2006
- Cardiac Myocyte Apoptosis Is Associated With Increased DNA Damage and Decreased Survival in Murine Models of ObesityCirculation Research, 2006
- Chronic Cardiovascular and Renal Actions of LeptinHypertension, 2002